Development and validation of an analytical method using High Performance Liquid Chromatography (HPLC) to determine ethyl butylacetylaminopropionate in topical repellent formulations

Detalhes bibliográficos
Autor(a) principal: Pinto, Isadora Cabral
Data de Publicação: 2017
Outros Autores: Cerqueira-Coutinho, Cristal, Freitas, Zaida Maria Faria de, Santos, Elisabete Pereira dos, Carmo, Flávia Almada do, Ricci Junior, Eduardo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/134158
Resumo: Diseases caused by insects are frequent in poor countries, leading to epidemic scenarios in urban areas; e.g., Dengue, Zika and Chikungunya. For this reason, the development of a safe and efficient topical formulation is essential. Ethyl butylacetylaminopropionate (EB) is a mosquito repellent developed by Merck, which is used in products for adults, children and especially babies, due to its low allergenic potential. The aim of this work was to validate an analytical methodology to quantify EB in a new poloxamer-based formulation by high-performance liquid chromatography (HPLC). The quantification methodology was performed at 40 ºC using a Kromasil reverse-phase column (C18), with the dimensions of 250 x 4.6 mm. The mobile phase was acetonitrile:water (1:1) at a 1.0 mL/min flow-rate. The detector wavelength was set at 218 nm to detect EB. The methodology was considered validated since the results indicated linearity (R2>;0.99), specificity, selectivity, precision and accuracy (active recovery between 98% and 102%). It also presented limits of detection and quantification of 0.255 µg/mL and 0.849 µg/mL, respectively. The present study demonstrated the EB vehiculated in poloxamer gel is promising as a new insect repellent formulation, since it could be quantified and quality control evaluated.
id USP-31_98361d3e2d9243caa7b096b56c92e058
oai_identifier_str oai:revistas.usp.br:article/134158
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Development and validation of an analytical method using High Performance Liquid Chromatography (HPLC) to determine ethyl butylacetylaminopropionate in topical repellent formulationsEthyl butylacetylaminopropionate (EB)/quantificationEthyl butylacetylaminopropionate (EB)/topical formulationsAnalytical methodValidationRepellentsProphylaxisHigh Performance Liquid Chromatography. Diseases caused by insects are frequent in poor countries, leading to epidemic scenarios in urban areas; e.g., Dengue, Zika and Chikungunya. For this reason, the development of a safe and efficient topical formulation is essential. Ethyl butylacetylaminopropionate (EB) is a mosquito repellent developed by Merck, which is used in products for adults, children and especially babies, due to its low allergenic potential. The aim of this work was to validate an analytical methodology to quantify EB in a new poloxamer-based formulation by high-performance liquid chromatography (HPLC). The quantification methodology was performed at 40 ºC using a Kromasil reverse-phase column (C18), with the dimensions of 250 x 4.6 mm. The mobile phase was acetonitrile:water (1:1) at a 1.0 mL/min flow-rate. The detector wavelength was set at 218 nm to detect EB. The methodology was considered validated since the results indicated linearity (R2>;0.99), specificity, selectivity, precision and accuracy (active recovery between 98% and 102%). It also presented limits of detection and quantification of 0.255 µg/mL and 0.849 µg/mL, respectively. The present study demonstrated the EB vehiculated in poloxamer gel is promising as a new insect repellent formulation, since it could be quantified and quality control evaluated.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2017-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/13415810.1590/s2175-97902017000216033Brazilian Journal of Pharmaceutical Sciences; Vol. 53 Núm. 2 (2017); e16033-Brazilian Journal of Pharmaceutical Sciences; v. 53 n. 2 (2017); e16033-Brazilian Journal of Pharmaceutical Sciences; Vol. 53 No. 2 (2017); e16033-2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/134158/129976Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)info:eu-repo/semantics/openAccessPinto, Isadora CabralCerqueira-Coutinho, CristalFreitas, Zaida Maria Faria deSantos, Elisabete Pereira dosCarmo, Flávia Almada doRicci Junior, Eduardo2017-06-29T17:40:27Zoai:revistas.usp.br:article/134158Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2017-06-29T17:40:27Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Development and validation of an analytical method using High Performance Liquid Chromatography (HPLC) to determine ethyl butylacetylaminopropionate in topical repellent formulations
title Development and validation of an analytical method using High Performance Liquid Chromatography (HPLC) to determine ethyl butylacetylaminopropionate in topical repellent formulations
spellingShingle Development and validation of an analytical method using High Performance Liquid Chromatography (HPLC) to determine ethyl butylacetylaminopropionate in topical repellent formulations
Pinto, Isadora Cabral
Ethyl butylacetylaminopropionate (EB)/quantification
Ethyl butylacetylaminopropionate (EB)/topical formulations
Analytical method
Validation
Repellents
Prophylaxis
High Performance Liquid Chromatography.
title_short Development and validation of an analytical method using High Performance Liquid Chromatography (HPLC) to determine ethyl butylacetylaminopropionate in topical repellent formulations
title_full Development and validation of an analytical method using High Performance Liquid Chromatography (HPLC) to determine ethyl butylacetylaminopropionate in topical repellent formulations
title_fullStr Development and validation of an analytical method using High Performance Liquid Chromatography (HPLC) to determine ethyl butylacetylaminopropionate in topical repellent formulations
title_full_unstemmed Development and validation of an analytical method using High Performance Liquid Chromatography (HPLC) to determine ethyl butylacetylaminopropionate in topical repellent formulations
title_sort Development and validation of an analytical method using High Performance Liquid Chromatography (HPLC) to determine ethyl butylacetylaminopropionate in topical repellent formulations
author Pinto, Isadora Cabral
author_facet Pinto, Isadora Cabral
Cerqueira-Coutinho, Cristal
Freitas, Zaida Maria Faria de
Santos, Elisabete Pereira dos
Carmo, Flávia Almada do
Ricci Junior, Eduardo
author_role author
author2 Cerqueira-Coutinho, Cristal
Freitas, Zaida Maria Faria de
Santos, Elisabete Pereira dos
Carmo, Flávia Almada do
Ricci Junior, Eduardo
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Pinto, Isadora Cabral
Cerqueira-Coutinho, Cristal
Freitas, Zaida Maria Faria de
Santos, Elisabete Pereira dos
Carmo, Flávia Almada do
Ricci Junior, Eduardo
dc.subject.por.fl_str_mv Ethyl butylacetylaminopropionate (EB)/quantification
Ethyl butylacetylaminopropionate (EB)/topical formulations
Analytical method
Validation
Repellents
Prophylaxis
High Performance Liquid Chromatography.
topic Ethyl butylacetylaminopropionate (EB)/quantification
Ethyl butylacetylaminopropionate (EB)/topical formulations
Analytical method
Validation
Repellents
Prophylaxis
High Performance Liquid Chromatography.
description Diseases caused by insects are frequent in poor countries, leading to epidemic scenarios in urban areas; e.g., Dengue, Zika and Chikungunya. For this reason, the development of a safe and efficient topical formulation is essential. Ethyl butylacetylaminopropionate (EB) is a mosquito repellent developed by Merck, which is used in products for adults, children and especially babies, due to its low allergenic potential. The aim of this work was to validate an analytical methodology to quantify EB in a new poloxamer-based formulation by high-performance liquid chromatography (HPLC). The quantification methodology was performed at 40 ºC using a Kromasil reverse-phase column (C18), with the dimensions of 250 x 4.6 mm. The mobile phase was acetonitrile:water (1:1) at a 1.0 mL/min flow-rate. The detector wavelength was set at 218 nm to detect EB. The methodology was considered validated since the results indicated linearity (R2>;0.99), specificity, selectivity, precision and accuracy (active recovery between 98% and 102%). It also presented limits of detection and quantification of 0.255 µg/mL and 0.849 µg/mL, respectively. The present study demonstrated the EB vehiculated in poloxamer gel is promising as a new insect repellent formulation, since it could be quantified and quality control evaluated.
publishDate 2017
dc.date.none.fl_str_mv 2017-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/134158
10.1590/s2175-97902017000216033
url https://www.revistas.usp.br/bjps/article/view/134158
identifier_str_mv 10.1590/s2175-97902017000216033
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/134158/129976
dc.rights.driver.fl_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 53 Núm. 2 (2017); e16033-
Brazilian Journal of Pharmaceutical Sciences; v. 53 n. 2 (2017); e16033-
Brazilian Journal of Pharmaceutical Sciences; Vol. 53 No. 2 (2017); e16033-
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222913244168192